Concepedia

Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study

Giovanna Rotondo Dottore, Liborio Torregrossa, Giulia Lanzolla, Stefano Mariotti, Francesca Menconi, Paolo Piaggi, Lodovica Cristofani Mencacci, Chiara Posarelli, Maria Novella Maglionico, Iacopo Dallan,

Journal of Endocrinological Investigation · 2021 · 16 citations · 15 references

DOI

Concepts

References

15

The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy

Luigi Bartalena, George J. Kahaly, L. Baldeschi et al. · European Journal of Endocrinology · 2021 · 977 citations · Full text

, , +17

Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

Maarten P. Mourits, Leo Koornneef, Wilmar M. Wiersinga et al. · British Journal of Ophthalmology · 1989 · 710 citations · Full text

, , +13

Teprotumumab for the Treatment of Active Thyroid Eye Disease

Raymond S. Douglas, George J. Kahaly, Amy Patel et al. · New England Journal of Medicine · 2020 · 700 citations · Full text

, , +11

Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial

J.V. Pérez-Moreiras, Juan J. Gómez‐Reino, José Ramón Maneiro et al. · American Journal of Ophthalmology · 2018 · 288 citations

, , +6

Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial

George J. Kahaly, Michaela Riedl, J. König et al. · The Lancet Diabetes & Endocrinology · 2018 · 216 citations

, , +9